Valeant Pharmaceuticals International, Inc. 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Aug 5, 2016
Insider Transaction Report
Form 4
Rosiello Robert L.
EVP, Chief Financial Officer
Transactions
- Tax Payment
Common Stock, no par value
2016-08-03$23.54/sh−1,338$31,497→ 533,187 total
Footnotes (1)
- [F1]This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.